SCHEMBL487368

SCHEMBL487368

O=C(O)c1cnc(Br)c(Br)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 5/20 0.50
POLB P06746 1/20 0.50
TTR P02766 1/20 0.50
P4HA1 P13674 3/20 0.47
P4HTM Q9NXG6 2/20 0.47
MIF P14174 1/20 0.47
MGAM O43451 1/20 0.44
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 4/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30792836 1.00 HCAR2 (0.50) HCAR2POLBTTRP4HA1P4HTM
SCHEMBL7599288 0.83 KMT2A (0.52) HCAR2POLBTTRP4HA1P4HTM
SCHEMBL186549 0.83 KMT2A (0.52) HCAR2POLBTTRP4HA1P4HTM
SCHEMBL31276895 0.83 KMT2A (0.52) HCAR2POLBTTRP4HA1P4HTM
SCHEMBL29878417 0.81 TTR (0.54) HCAR2POLBTTRP4HA1P4HTM
SCHEMBL1505622 0.81 TTR (0.54) HCAR2POLBTTRP4HA1P4HTM
SCHEMBL28345746 0.81 HCAR2 (0.48) HCAR2POLBTTRP4HA1P4HTM
SCHEMBL9193957 0.81 CA5A (0.37) POLBTTRP4HA1P4HTMMIF
SCHEMBL31527392 0.81 HCAR2 (0.48) HCAR2POLBTTRP4HA1P4HTM
SCHEMBL487581 0.79 TPMT (0.48) HCAR2POLBTTRP4HA1P4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154105-A1 POLYCYCLIC COMPOUND AND USE THEREOF TYK MEDICINES, INC. (CN) 2025-05-15 US disclosed
EP-4385978-A1 POLYCYCLIC COMPOUND AND USE THEREOF TYK Medicines Inc. (CN) 2024-06-19 EP disclosed
CN-117677608-A Polycyclic compounds and uses thereof 浙江同源康医药股份有限公司 2024-03-08 CN disclosed
WO-2023016562-A1 POLYCYCLIC COMPOUND AND USE THEREOF 浙江同源康医药股份有限公司 2023-02-16 WO disclosed
WO-2023016562-A1 POLYCYCLIC COMPOUND AND USE THEREOF 浙江同源康医药股份有限公司 2023-02-16 WO disclosed
EP-2049488-B1 N'-CYANO-N-ALKYL HALIDE IMIDE AMIDE DERIVATIVES BAYER IP GMBH (DE) 2015-12-09 EP disclosed
CN-102321081-B Preparation method of substituted enaminocarbonyl compound used as insecticide and intermediate BAYER CROPSCIENCE AG 2015-05-20 CN disclosed
EP-2004636-B1 Substituted enaminocarbonyl compounds used as insecticides BAYER IP GMBH (DE) 2015-04-22 EP disclosed
EP-2844655-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS CRAC MODULATORS Lupin Limited (IN) 2015-03-11 EP disclosed
US-20140113824-A1 BICYCLIC (THIO)CARBONYLAMIDINES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-04-24 US disclosed
US-20090181947-A1 BICYCLIC ENAMINO(THIO)CARBONYL COMPOUNDS BAYER CROPSCIENCE AG (DE) 2009-07-16 US disclosed
CN-101460502-A Bicyclic enamino(thio)carbonyl compounds BAYER CROPSCIENCE AG (DE) 2009-06-17 CN disclosed
CN-101454316-A Substituted enaminocarbonyl compounds for use as pesticides BAYER CROPSCIENCE AG (DE) 2009-06-10 CN disclosed
CN-101415682-A Substituted enaminocarbonyl compounds BAYER CROPSCIENCE AG (DE) 2009-04-22 CN disclosed
EP-2021344-A1 BICYCLIC ENAMINO(THIO)CARBONYL COMPOUNDS Bayer CropScience AG (DE) 2009-02-11 EP disclosed
EP-2004636-A1 SUBSTITUTED ENAMINOCARBONYL COMPOUNDS USED AS INSECTICIDES Bayer CropScience AG (DE) 2008-12-24 EP disclosed
EP-2004606-A1 SUBSTITUTED ENAMINOCARBONYL COMPOUNDS Bayer CropScience AG (DE) 2008-12-24 EP disclosed
WO-2007115643-A1 SUBSTITUTED ENAMINOCARBONYL COMPOUNDS BAYER CROPSCIENCE AG (DE) 2007-10-18 WO disclosed
WO-2007115647-A1 BICYCLIC ENAMINO(THIO)CARBONYL COMPOUNDS BAYER CROPSCIENCE AG (DE) 2007-10-18 WO disclosed
WO-2007115646-A1 SUBSTITUTED ENAMINOCARBONYL COMPOUNDS USED AS INSECTICIDES BAYER CROPSCIENCE AG (DE) 2007-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181947-A1 BICYCLIC ENAMINO(THIO)CARBONYL COMPOUNDS TARS2, TBCA, DDT HCAR2 4477/4885POLB 4428/4885TTR 143/4885
US-20250154105-A1 POLYCYCLIC COMPOUND AND USE THEREOF YAP1, TEAD2, TEAD1 HCAR2 1964/4885POLB 3090/4885TTR 4728/4885
US-20140113824-A1 BICYCLIC (THIO)CARBONYLAMIDINES BROX, BOLA2; BOLA2B, CAT HCAR2 4183/4885POLB 3356/4885TTR 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.